Get Tysabri at BioHealth Infusion Center
About Tysabri
Tysabri (natalizumab) is used to treat relapsing and secondary progressive forms of multiple sclerosis (MS). It is also prescribed to treat moderately to severely active Crohn’s disease in patients for whom other treatments haven’t worked.
Tysabri is a a monoclonal antibody. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect other, healthy cells from damage.
In rare cases, Tysabri can cause a serious brain infection called PML that can lead to disability or death. In 2005, this led the manufacturer to take Tysabri off the market. Tysabri was reintroduced after the manufacturer developed a program to register patients and follow up regularly to find any possible cases of PML as soon as possible.
InfuseWell strictly observes these protocols, called the “Tysabri Touch” program.
Getting Your Tysabri Infusion
Tysabri is administered by intravenous infusion every four weeks. Each infusion takes about an hour.
Manufacturer:
First Approval:
Reintroduced:
Biogen, Inc
11/23/2004
3/8/2006
Get Tysabri at BioHealth Infusion Center and enjoy:
Perfect Medical Services
Schedule an Appointment
Our goal is to provide patients with courteous, prompt, and experienced infusion care. With just one phone call to the infusion center, the authorization process can begin immediately. All reimbursement and financial assistance options are explored in order to provide the patient’s infusion therapy at the lowest out-of-pocket costs to them.